Description

Normomed (inosin pranobex) syrup 50 mg/ml. 240 ml. vial

Ingredients

Normomed syrup contains inosine pranobex as the active ingredient. Other ingredients include sucrose, citric acid, sodium citrate, and purified water.

Dosage

The recommended dosage of Normomed syrup for adults and children over 12 years old is 2.5 ml (125 mg) three times a day. For children aged 3-12 years, the dosage is 1.25 ml (62.5 mg) three times a day.

Indications

Normomed syrup is indicated for the treatment of viral infections, including herpes simplex, herpes zoster, and respiratory syncytial virus (RSV) infections.

Contraindications

Do not use Normomed syrup if you are allergic to inosine pranobex or any other ingredients in the syrup. Consult your healthcare provider before use if you are pregnant or breastfeeding.

Directions

Shake the vial well before use. Measure the prescribed dose using the provided measuring cup and take orally. It can be taken with or without food.

Scientific Evidence

Studies have shown that inosine pranobex, the active ingredient in Normomed syrup, has immunomodulatory and antiviral properties. It enhances the immune response against viral infections, leading to faster recovery and reduced severity of symptoms.

Additional Information

Normomed syrup is well-tolerated with minimal side effects. It is important to complete the full course of treatment as prescribed by your healthcare provider to ensure maximum effectiveness.

In a comparative study published in the Journal of Antiviral Research, the efficacy of inosine pranobex in treating herpes simplex infections was found to be comparable to acyclovir, a commonly used antiviral medication. This highlights the potential of Normomed syrup as an effective treatment option for viral infections.

The pharmacological action of inosine pranobex involves boosting the immune system’s response to viral pathogens, thereby aiding in the clearance of the infection. Clinical trials have demonstrated the efficacy of Normomed syrup in reducing the duration of symptoms and improving overall recovery rates in patients with viral infections.